BRIEF-Jiangsu Hengrui Medicine in licensing agreement with Japan's Oncolys Biopharma

Dec 2 (Reuters) - Jiangsu Hengrui Medicine Co Ltd * Says it signs licensing agreement with Japan's Oncolys Biopharma on medicine telomelysin's sales in China, Hong Kong and Macau Source text in Chinese: http://bit.ly/2gPt1wc Further company coverage: (Reporting by Hong Kong newsroom)